|
parathyroid hormone (1-34)amide, Nle(8), Lys(N-epsilon-4-azido-2-nitrophenyl)(13), Nle(18), Tyr(34)-, bovine
|
C060826 |
|
|
Ro 31-6045
|
C456939 |
|
|
4-hydroxyphenoxyacetic acid
|
C060827 |
|
|
Prospective Payment Assessment Commission
|
D011444 |
[The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.
] |
|
NF-KappaB Inhibitor alpha
|
D000072000 |
[An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding.
] |
|
ADP reductase
|
C035880 |
|
|
Prospective Payment System
|
D011445 |
[A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims.
] |
|
Healthy Diet
|
D000072001 |
[Dietary patterns which have been found to be important in reducing disease risk.
] |
|
Prospective Studies
|
D011446 |
[Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
] |
|
Prion Proteins
|
D000072002 |
[Membrane glycosylphosphatidylinositol-anchored glycoproteins that may aggregate into rod-like structures. The prion protein (PRNP) gene is characterized by five TANDEM REPEAT SEQUENCES that encode a highly unstable protein region of five octapeptide repeats. Mutations in the repeat region and elsewhere in this gene are associated with CREUTZFELDT-JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GERSTMANN-STRAUSSLER DISEASE; Huntington disease-like 1, and KURU.
] |
|
cytase
|
C035882 |
|
|
Prospidium
|
D011447 |
[An antineoplastic dispiropiperazine derivative.
] |
|
bismuth phosphate
|
C035883 |
|
|
sabadilla
|
C442300 |
|
|
Prostaglandin Antagonists
|
D011448 |
[Compounds that inhibit the action of prostaglandins.
] |
|
atenolol, chlortalidone drug combinations
|
C035884 |
|
|
(3,5,5,8,8,-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl) (5 carboxypyrid-2-yl)sulfide
|
C442301 |
|
|
Prostaglandin Endoperoxides
|
D011449 |
[Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc.
] |
|
ferric phosphate
|
C035885 |
|
|
AKR7A1
|
C442302 |
|
